Skip to main content
Announcements

Sidley Represents Capricor Therapeutics in Common Stock Offering

October 24, 2024

Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.

The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.

Contacts

Carlson, Rob R.
Partner
DeAngelis, Nick
Counsel
Swaminathan, Nithya
Managing Associate

Capabilities

Suggested News & Insights

Financial Covenants in Private Credit TransactionsMarch 24, 2026
Private Credit Perspectives
SEC Releases Landmark Interpretation on Application of U.S. Securities Laws to Crypto Assets, in Coordination With CFTCMarch 24, 2026
Securities Enforcement and Regulatory Update
Sidley Advises on the Upsized US$966 Million IPO of Janus LivingMarch 23, 2026
Announcements
Sidley Ranked in Chambers Europe 2026March 19, 2026
Accolades
Sidley Represents Kodiak Gas Services in US$1 Billion Senior Notes OfferingMarch 16, 2026
Announcements
Bloomberg Ranks Sidley No. 1 for Equity Capital Markets by Deal Value in Australia and New Zealand in 2025March 13, 2026
Announcements